Citation Impact
Citing Papers
Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis
2010 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies
2011
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Risk Factors for Venous Thromboembolism
2003 Standout
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Infective Endocarditis
2005 Standout
Recent insights into antiphospholipid antibody-mediated thrombosis
1999
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Pulmonary Embolism
1998
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study
1999
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 Standout
Management of the obstetric antiphospholipid syndrome
2004
Point-of-care testing of the international normalized ratio in patients with antiphospholipid antibodies
2005
Recurrent Venous Thromboembolism After Deep Vein Thrombosis
2000
Evidence-Based Management of Anticoagulant Therapy
2012
The role of tissue factor in the antiphospholipid syndrome
2001
Treatment of Pulmonary Arterial Hypertension
2004 Standout
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
2011 Standout
Monitoring of oral anticoagulant therapy in lupus anticoagulant positive patients with the anti‐phospholipid syndrome
1997
EPIDEMIOLOGY OF THE VASCULITIDES
2001
Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy
2002 Standout
Reporting Standards for Endovascular Treatment of Lower Extremity Deep Vein Thrombosis
2006
Guidelines on the investigation and management of antiphospholipid syndrome
2012
Antiphospholipid antibodies in adults with immune thrombocytopenic purpura
2008
Antithrombotic Therapy for VTE Disease
2016 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
1998
The role of vena caval filters in the management of venous thromboembolism
2004
Primary pulmonary hypertension: Current therapy
2002
Bleeding and re-thrombosis in primary antiphospholipid syndrome on oral anticoagulation
2005
Prognostic Value of ECG Among Patients with Acute Pulmonary Embolism and Normal Blood Pressure
2009
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
Systemic lupus erythematosus
2001
Clinical classification of pulmonary hypertension
2004 Standout
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
2000
A randomized clinical trial of high‐intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)
2005
Venous Thromboembolism during Pregnancy
1996
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
2003 Standout
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism
2004 Standout
Managing Oral Anticoagulant Therapy
2001
A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome
2003
Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: Prevalence, clinical associations, and long‐term outcome
2004
Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome
2010
The risk of recurrent venous thromboembolism: The Austrian Study on Recurrent Venous Thromboembolism
2003
The Antiphospholipid Syndrome
2002 Standout
Sneddon Syndrome with or without Antiphospholipid Antibodies: A Comparative Study in 46 Patients
1999
Systemic Lupus Erythematosus
2011 Standout
Oral Anticoagulants
1998
Prevention of Venous Thromboembolism
2004 Standout
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 Standout
Guidelines On The Investigation and Management Of The Antiphospholipid Syndrome
2000
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
2001 Standout
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
The Incidence of Recurrent Venous Thromboembolism After Treatment With Vitamin K Antagonists in Relation to Time Since First Event
2003
Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.
1996
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
2005 Standout
Vascular-Bed–Specific Hemostasis and Hypercoagulable States
1999
Thrombophilic factors in chronic thromboembolic pulmonary hypertension
2001
Anticardiolipin Antibodies Predict Early Recurrence of Thromboembolism and Death Among Patients with Venous Thromboembolism Following Anticoagulant Therapy
1998
Disseminated Intravascular Coagulation
1999 Standout
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
The Risk of Recurrent Venous Thromboembolism in Men and Women
2004
Stroke and pregnancy
2007
Deep vein thrombosis
2005
Complications of Femoral and Subclavian Venous Catheterization in Critically Ill Patients<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001 Standout
Antiphospholipid syndrome and the skin
1997
Management of Venous Thromboembolism
1996
Antithrombotic Therapy for Venous Thromboembolic Disease
2004 Standout
How much warfarin is enough in APS related thrombosis?
2004
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the italian registry
1996
Cutaneous manifestations associated with antiphospholipid antibodies
2004
Effects of human soluble thrombomodulin on experimental glomerulonephritis
2002 StandoutNobel
Venous Thromboembolism
1999
Impact of the patient population on the risk for heparin-induced thrombocytopenia
2000 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
2006 Standout
Upper-Extremity Deep Vein Thrombosis
2002
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
2017 Standout
Combination Therapy with Pulse Cyclophosphamide plus Pulse Methylprednisolone Improves Long-Term Renal Outcome without Adding Toxicity in Patients with Lupus Nephritis
2001
The Risk of Early Recurrent Venous Thromboembolism after Oral Anticoagulant Therapy in Patients with the G20210A Transition in the Prothrombin Gene
1999
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis
2000
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
2002 Standout
Primary Prevention of Ischemic Stroke
2001
Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis
2000
Review : Elevated levels of anticardiolipin antibodies and epilepsy in lupus patients
1996
Antiphospholipid Antibodies and Subsequent Thrombo-occlusive Events in Patients With Ischemic Stroke
2004
Control of Oral Anticoagulation in Patients with the Antiphospholipid Syndrome – Influence of the Lupus Anticoagulant on International Normalized Ratio
1998
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature
2003
Antiphospholipid antibodies and venous thromboembolism
1995
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Warfarin plus Aspirin after Myocardial Infarction or the Acute Coronary Syndrome: Meta-Analysis with Estimates of Risk and Benefit
2005
Heart Valve Involvement (Libman-Sacks Endocarditis) in the Antiphospholipid Syndrome
1996
Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002
2003
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Primary Prevention of Ischemic Stroke
2001
The Epidemiology of Venous Thromboembolism
2003 Standout
Annexins: From Structure to Function
2002 Standout
The Effects of Low-intensity Warfarin on Coagulation Activation in Patients with Antiphospholipid Antibodies and Systemic Lupus Erythematosus
1999
Warfarin-related outcomes in patients with antiphospholipid antibody syndrome managed in an anticoagulation clinic
2006
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome
2004
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of oral anticoagulant therapy.
1998
Management of Deep Vein Thrombosis and Pulmonary Embolism
1996
Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications.
1997
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Residual Venous Thrombosis as a Predictive Factor of Recurrent Venous Thromboembolism
2002
Works of F Mujić being referenced
ALLERGIC DISORDERS IN SYSTEMIC VASCULITIS: A CASE-CONTROLLED STUDY
1994
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
1995 Standout
Thrombocytopenia in the antiphospholipid syndrome
1997
Immunosuppressive therapy in lupus nephritis.
1997
Prevalence and clinical significance of subungual splinter haemorrhages in patients with the antiphospholipid syndrome.
1995